Recent Resources
Blog
Risk Assessment for use of Engineered Genetic Materials in Clinical Research
Learn why an institutional biosafety committee needs to complete a risk assessment for engineered genetic material in clinical research.
Read Now
4 min. read
Read more
Webinar
Full Board vs Expedited vs Exempt: Why IRBs do That
Upcoming: April 20
A discussion on what IRBs must consider, what might tip the scales for a study that could go either way, and what “expedited review” means.
Register Now
Read more
Blog
How Single IRB Review Mandates Help Research Sponsors
The proposed single IRB mandates will impact FDA-regulated research, potentially altering existing practices at organizations.
Read Now
4 min. read
Read more
